Clinical Information
patient
|
2-S25 |
Age
|
30 |
Dose(mg)
|
1 |
Cervical lesion size
|
>50% |
V1(Histology)
|
CIN3 |
V1 (HPV)
|
16, 18, LR |
V7(Histology)
|
CIN3 |
V7 (HPV)
|
16,LR |
V7 histopatholgic regression
|
No |
V7 HPV clearance
|
No |
Included in V7 (20weeks after 1st injection)analysis
|
Yes |
|
|